SGHT
Sight SciencesFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Execution on EU expansion, TearCare Plus rollouts, and reimbursement gains drive accelerating revenue and margin expansion, supporting re‑rating toward $12.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -1.7.
What can break
Adverse reimbursement decisions
Momentum
5
Value
36
Sentiment
75
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.75 · Bull $12.00 · Bear $5.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-16 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $9.68
Why
Momentum5 · Δ7d +1.3
Value36 · Δ7d -0.0
Sentiment75 · Δ7d -1.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
5
34% active weight
Current posture
7d trendImproving
Δ7d
+1.3
Δ21d
+1.4
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
75
33% active weight
Current posture
7d trendFlat
Δ7d
-1.7
Δ21d
+1.1
Why this grade
Composite grade F. Momentum 5.3 / Value 36.4 / Sentiment 74.7
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$236.14M
Beta
2.41
Shares Out
52.87M
P/E (TTM) · Derived
-4.3
P/S (TTM)
5.36
P/FCF (TTM) · Derived
-7.23
Rev YoY
-1.2%
EPS YoY
+29.1%
Gross Margin
+86.8%
Op Margin
-59.6%
Net Debt
-$81M
Current Ratio
9.60
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology